📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency. (2021)

First Author: Kohn DB

Attributed to: Phase I/II trial of lentiviral vector mediated gene therapy for Adenosine Deaminase deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2027675

PubMed Identifier: 33974366

Publication URI: http://europepmc.org/abstract/MED/33974366

Type: Journal Article/Review

Volume: 384

Parent Publication: The New England journal of medicine

Issue: 21

ISSN: 0028-4793